<!DOCTYPE html>
<html lang="en-us">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.5.0">

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Sam Robson">

  
  
  
    
  
  <meta name="description" content="Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies. Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction. Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC2, 3 and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin ‘adaptor’ proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL–AF9 and human MLL–AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias.">

  
  <link rel="alternate" hreflang="en-us" href="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.6.0/css/all.css" integrity="sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.css" integrity="sha512-M2wvCLH6DSRazYeZRIm1JnYyh22purTM+FDB5CsyxtQJYeKq83arPe5wgbNmcFXGqiSH2XR8dT/fJISVA1r/zQ==" crossorigin="anonymous">
    

    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  <link rel="stylesheet" href="/css/academic.min.1884ccbe79662c38d99b291260b58a24.css">

  

  




  


  

  <link rel="manifest" href="/index.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon-32.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/">

  
  
  
  
    
  
  
  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="IRunFasterThanMyCode">
  <meta property="og:url" content="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/">
  <meta property="og:title" content="Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia | IRunFasterThanMyCode">
  <meta property="og:description" content="Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies. Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction. Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC2, 3 and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin ‘adaptor’ proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL–AF9 and human MLL–AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias."><meta property="og:image" content="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/featured.png">
  <meta property="twitter:image" content="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/featured.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2011-10-02T00:00:00&#43;00:00">
    
    <meta property="article:modified_time" content="2011-10-02T00:00:00&#43;00:00">
  

  


    











<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/"
  },
  "headline": "Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia",
  
  "image": [
    "/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/featured.png"
  ],
  
  "datePublished": "2011-10-02T00:00:00Z",
  "dateModified": "2011-10-02T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Dawson MA"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "IRunFasterThanMyCode",
    "logo": {
      "@type": "ImageObject",
      "url": "/img/irunfasterthanmycode.jpg"
    }
  },
  "description": "Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies. Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction. Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC2, 3 and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin ‘adaptor’ proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL–AF9 and human MLL–AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias."
}
</script>

  

  


  


  





  <title>Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia | IRunFasterThanMyCode</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  
<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/"><img src="/img/irunfasterthanmycode.jpg" alt="IRunFasterThanMyCode"></a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav mr-auto">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#about"><span>Home</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#posts"><span>Posts</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#projects"><span>Projects</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#featured"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#resources"><span>Resources</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/resources/rtutorial/index.html"><span>R</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/resources/pythontutorial/index.html"><span>Python</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contact</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/cv/SamRobson_CV_Academic.pdf"><span>CV</span></a>
        </li>

        
        

      
      </ul>
      <ul class="navbar-nav ml-auto">
      

        

        
        <li class="nav-item">
          <a class="nav-link js-search" href="#"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        

        
        <li class="nav-item">
          <a class="nav-link js-dark-toggle" href="#"><i class="fas fa-moon" aria-hidden="true"></i></a>
        </li>
        

      </ul>

    </div>
  </div>
</nav>


  <div class="pub">

  




















  
  
    
  


<div class="article-container pt-3">
  <h1>Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</h1>

  

  



<div class="article-metadata">

  
  
  
  
  <div>
    



  
  <span><a href="/authors/dawson-ma/">Dawson MA</a></span>, <span><a href="/authors/prinjha-rk/">Prinjha RK</a></span>, <span><a href="/authors/dittmann-a/">Dittmann A</a></span>, <span><a href="/authors/giotopoulos-g/">Giotopoulos G</a></span>, <span><a href="/authors/bantscheff-m/">Bantscheff M</a></span>, <span><a href="/authors/chan-wi/">Chan WI</a></span>, <span><a href="/authors/samrobson/">Sam Robson</a></span>, <span><a href="/authors/chung-cw/">Chung CW</a></span>, <span><a href="/authors/hopf-c/">Hopf C</a></span>, <span><a href="/authors/savitski-mm/">Savitski MM</a></span>, <span><a href="/authors/huthmacher-c/">Huthmacher C</a></span>, <span><a href="/authors/gudgin-e/">Gudgin E</a></span>, <span><a href="/authors/lugo-d/">Lugo D</a></span>, <span><a href="/authors/beinke-s/">Beinke S</a></span>, <span><a href="/authors/chapman-td/">Chapman TD</a></span>, <span><a href="/authors/roberts-ej/">Roberts EJ</a></span>, <span><a href="/authors/soden-pe/">Soden PE</a></span>, <span><a href="/authors/auger-kr/">Auger KR</a></span>, <span><a href="/authors/mirguet-o/">Mirguet O</a></span>, <span><a href="/authors/doehner-k/">Doehner K</a></span>, <span><a href="/authors/delwel-r/">Delwel R</a></span>, <span><a href="/authors/burnett-ak/">Burnett AK</a></span>, <span><a href="/authors/jeffrey-p/">Jeffrey P</a></span>, <span><a href="/authors/drewes-g/">Drewes G</a></span>, <span><a href="/authors/lee-k/">Lee K</a></span>, <span><a href="/authors/huntly-bj/">Huntly BJ</a></span>, <span><a href="/authors/kouzarides-t/">Kouzarides T</a></span>

  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    October 2011
  </span>
  

  

  

  
  
  
  <span class="middot-divider"></span>
  <a href="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/#disqus_thread"></a>
  

  
  

  
    
<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/&amp;text=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/&amp;t=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook-f"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia&amp;body=/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/&amp;title=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://web.whatsapp.com/send?text=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia%20/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/&amp;title=Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>


  

</div>

  













<div class="btn-links mb-3">
  
  








  
    
  



<a class="btn btn-outline-primary my-1 mr-1" href="/pdf/mypapers/2011_Dawson_Inhibition%20of%20BET%20recruitment%20to%20chromatin%20as%20an%20effective%20treatment%20for%20MLL-fusion%20leukaemia.pdf" target="_blank" rel="noopener">
  PDF
</a>

















</div>


</div>


<div class="article-header article-container featured-image-wrapper mt-4 mb-4" style="max-width: 720px; max-height: 138px;">
  <div style="position: relative">
    <img src="/publication/2011_inhibition_of_bet_recruitment_to_chromatin_as_an_effective_treatment_for_mll-fusion_leaukemia/featured_hu67a01365280162a77136d0c5ddfde1c0_1050334_720x0_resize_lanczos_2.png" alt="" class="featured-image">
    
  </div>
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies. Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction. Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC2, 3 and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin ‘adaptor’ proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL–AF9 and human MLL–AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            
            <a href="/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">Nature. 2011 Oct 2;478(7370):529-33</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    

<div class="article-tags">
  
  <a class="badge badge-light" href=""></a>
  
</div>


    








  
  
    
  
  






  
  
  
  
  <div class="media author-card">
    

    <div class="media-body">
      <h5 class="card-title"><a href="/authors/dawson-ma/"></a></h5>
      
      
      <ul class="network-icon" aria-hidden="true">
  
</ul>

    </div>
  </div>




    
<section id="comments">
  
    
<div id="disqus_thread"></div>
<script>
  let disqus_config = function () {
    
    
    
  };
  (function() {
    if (["localhost", "127.0.0.1"].indexOf(window.location.hostname) != -1) {
      document.getElementById('disqus_thread').innerHTML = 'Disqus comments not available by default when the website is previewed locally.';
      return;
    }
    var d = document, s = d.createElement('script'); s.async = true;
    s.src = 'https://' + "https-irunfasterthanmycode-github-io" + '.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
  })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
<a href="https://disqus.com" class="dsq-brlink">comments powered by <span class="logo-disqus">Disqus</span></a>


  
</section>



  </div>
</div>



      

    
    
    
    <script src="/js/mathjax-config.js"></script>
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/highlight.min.js" integrity="sha256-aYTdUrn6Ow1DDgh5JTc3aDGnnju48y/1c8s1dgkYPQ8=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/languages/r.min.js"></script>
        
      

      
      
      <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS_CHTML-full" integrity="sha256-GhM+5JHb6QUzOQPXSJLEWP7R73CbkisjzK5Eyij4U9w=" crossorigin="anonymous" async></script>
      
    

    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.js" integrity="sha512-lInM/apFSqyy1o6s89K4iQUKg6ppXEgsVxT35HbzUupEVRh2Eu9Wdl4tHj7dZO0s1uvplcYGmt3498TtHq+log==" crossorigin="anonymous"></script>
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    
    <script id="dsq-count-scr" src="https://https-irunfasterthanmycode-github-io.disqus.com/count.js" async></script>
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/js/academic.min.d6bd04fdad2ad213aa8111c5a3b72fc5.js"></script>

    






  
  <div class="container">
    <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2017 Sam Robson &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" class="back-to-top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
